Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy

This publication has 15 references indexed in Scilit:

• Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study)
  Radiotherapy and Oncology, 1993
• Selection bias, survival, and brachytherapy for glioma
  Journal of Neurosurgery, 1992
• Prognostic factors for high-grade malignant glioma: Development of a prognostic index
  Journal of Neuro-Oncology, 1990
• Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factors
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Response criteria for phase II studies of supratentorial malignant glioma.
  Journal of Clinical Oncology, 1990
• Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
  International Journal of Radiation Oncology*Biology*Physics, 1990
• High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma
  British Journal of Cancer, 1988
• Successful chemotherapy for recurrent malignant oligodendroglioma
  Annals of Neurology, 1988
• Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study
  Cancer, 1983
• Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study
  Journal of Neuro-Oncology, 1983